Biocon

Biocon chief Kiran Mazumdar-Shaw tests positive for COVID-19

Biocon chief Kiran Mazumdar-Shaw tests positive for COVID-19

Bengaluru: Biocon chairperson Kiran Mazumdar-Shaw on Monday night said she tested COVID-19 positive."I have added to the COVID count by t...Read More

Biocon shares decline nearly 4 pc after Q1 earnings

Biocon shares decline nearly 4 pc after Q1 earnings

New Delhi: Shares of biotechnology major Biocon on Friday dropped nearly 4 per cent after the company reported a 26.30 per cent decline i...Read More

DCGI permits use of Biocon Biologics’ CytoSorb to treat COVID-19 patients

DCGI permits use of Biocon Biologics’ CytoSorb to treat COVID-19 patients

Biocon’s subsidiary Biocon Biologics has received Drugs Controller General of India’s (DCGI) approval to use CytoSorb to treat critical C...Read More

Biocon Q4 net profit falls 42 pc to Rs 123 cr due to one-time COVID-19 impact

Biocon Q4 net profit falls 42 pc to Rs 123 cr due to one-time COVID-19 impact

The company had posted a net profit of Rs 214 crore for the corresponding period of the previous fiscal, Biocon said in a statement.

Biocon, Mylan launch Fulphila, biosimilar Pegfilgrastim in Australia

Biocon, Mylan launch Fulphila, biosimilar Pegfilgrastim in Australia

Biocon Ltd. and Mylan N V on Tuesday announced the launch of Fulphila, a biosimilar to Neulasta (pegfilgrastim), in Australia.

Biotechnology major Biocon Q3 net dips 7% to Rs 203 crore

Biotechnology major Biocon Q3 net dips 7% to Rs 203 crore

The company had posted a net profit of Rs 217.2 crore for the corresponding period of the previous fiscal, Biocon said.

True North to get 2.4% Biocon arm stake

True North to get 2.4% Biocon arm stake

New Delhi: Pharmaceuticals major Biocon Ltd on Monday said that its subsidiary Biocon Biologics India has approved the acquisition of 2.4...Read More

Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infosys matter

Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infosys matter

Mazumdar Shaw, who is also a chairman of Biocon, was alleged to have violated provisions of the Prohibition of Insider Trading (PIT) regu...Read More

Biocon net at Rs 216 cr for the quarter ended September

Biocon net at Rs 216 cr for the quarter ended September

New Delhi: Biotechnology major Biocon reported a net profit of Rs 215.7 crore for the quarter ended September 30, 2019.The company had p...Read More

It’s a truce says, Biocon chief Kiran Mazumdar Shaw

It’s a truce says, Biocon chief Kiran Mazumdar Shaw

On Thursday Finance Minister Nirmala Sitharaman had defended her decision to ban e-cigarettes after Biocon chief Kiran Mazumdar-Shaw ques...Read More

“I've been working on the economy, tweets FM after criticism

“I've been working on the economy, tweets FM after criticism

Reminds Biocon chief of govt's fiscal steps on growth revival

Biocon Q1 net profit up 72 per cent to Rs 206.3 crore

Biocon Q1 net profit up 72 per cent to Rs 206.3 crore

Biocon reported a 72.34 per cent rise in consolidated net profit to Rs 206.3 crore for the quarter ended on June 30, 2019 mainly on accou...Read More

USFDA issues 12 observations for 3 Biocon units in Malaysia

USFDA issues 12 observations for 3 Biocon units in Malaysia

"The inspection across these three units concluded with 12 observations issued on the Form 483"

European Commission okays Mylan, Biocon’s biosimilar of cancer drug

European Commission okays Mylan, Biocon’s biosimilar of cancer drug

New Delhi: Biotechnology major Biocon on Wednesday said the European Commission has approved and granted marketing authorisation to its b...Read More

placeholder

Licence raj replaced by time-consuming approval raj: Biocon CMD Kiran Mazumdar-Shaw

Hyderabad : India may have created a competitive market by abolishing licence raj, but it has been replaced by an equally time-consuming ...Read More

Biocon initiates ‘Ek Prayaas’ nationwide awareness program on Hepatitis C

Biocon initiates ‘Ek Prayaas’ nationwide awareness program on Hepatitis C

New Delhi : Biocon branded formulations business announced the launch of a new patient support program ‘Ek Prayaas’ through a nationwide ...Read More

placeholder

PepsiCo, Biocon to set up facilities in Karnataka

Bengaluru : The Karnataka government on Wednesday approved three projects, including that of PepsiCo India and Biocon, committing total i...Read More

Biocon gets nod to sell diabetes product in Japan

Biocon gets nod to sell diabetes product in Japan

New Delhi: Biocon has received approval from the Japanese health authority to sell its biosimilar product ‘Insulin Glargine’ in that coun...Read More

Health Ministry in dark on life-saving drugs made costlier

Health Ministry in dark on life-saving drugs made costlier

New Delhi: In a typical example of the government’s one arm not knowing what other arm is doing, the Health Ministry has been taken aback...Read More

Better days for reform agenda?

Better days for reform agenda?

After 18 months of eye-ball-to-eye-ball confrontation in Parliament, the BJP and the Congress have realised that hubris and negativism wi...Read More

Free Press Journal

www.freepressjournal.in